Skip to main content

IFN-alpha F/IFNA21 Antibody (C1)

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-41923

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP3-41923

Key Product Details

Species Reactivity

Human, Porcine

Applications

Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG2b Kappa Clone # C1

Concentration

1 mg/ml

Product Specifications

Immunogen

Immunized with recombinant Human IFN-alpha F/IFNA21 (Uniprot#: P01568; Asp25-Glu189 (Uniprot#: P01568)

Clonality

Monoclonal

Host

Mouse

Isotype

IgG2b Kappa

Applications for IFN-alpha F/IFNA21 Antibody (C1)

Application
Recommended Usage

Immunocytochemistry/ Immunofluorescence

5-20ug/mL

Immunohistochemistry

5-20ug/mL

Western Blot

0.5-2ug/mL

Formulation, Preparation, and Storage

Purification

Protein A or G purified

Formulation

0.01M PBS, pH7.4, 50% glycerol

Preservative

0.05% Proclin 300

Concentration

1 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: IFN-alpha 21/IFNA21

Produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase

Long Name

Interferon alpha F

Alternate Names

IFN-alpha F, IFNA21, IFNalpha F

Gene Symbol

IFNA21

Additional IFN-alpha 21/IFNA21 Products

Product Documents for IFN-alpha F/IFNA21 Antibody (C1)

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for IFN-alpha F/IFNA21 Antibody (C1)

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...